MARKET IS OPEN
Loading latest tickers...
Market Indices
S&P 500
$7,666.45
+0.19%
NASDAQ 100
$30,501.56
+0.31%
DOW JONES
$50,927.00
+0.04%
NASDAQ Composite
$26,871.60
+0.04%
RUSSELL 2000
$2,790.20
+0.41%
CBOE VIX
$16.39
+0.31%
Sector Heatmap
Technology+1.05%
Financials+0.11%
Healthcare-1.32%
Consumer Cycl-0.03%
Consumer Staples-0.33%
Energy+1.95%
Industrials+0.99%
Materials-0.33%
Real Estate-0.56%
Utilities+0.61%
Comm Services-0.93%
ALLO — Allogene Therapeutics, Inc. Common Stock
NasdaqAllogene Therapeutics, Inc. Common Stock
$1.54
-0.06(-3.75%)
- O
- 1.60
- H
- 1.61
- L
- 1.53
- V
- 4.57M
⏱️ End-of-day dataAs of Oct 1, 2026
ALLO — Financial Statements
Historical 2-Year Statements| Financial Metric / Line Item | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|---|---|
| Fiscal Date | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| Period | quarterly | quarterly | quarterly | quarterly | quarterly | quarterly |
| Year | 2,026.00 | 2,025.00 | 2,025.00 | 2,025.00 | 2,025.00 | 2,024.00 |
| Cash And Cash Equivalents | $30.31M | $51.69M | $37.81M | $52.33M | $42.45M | $75.22M |
| Other Short Term Investments | $23.66M | $19.85M | $21.44M | $22.08M | $23.76M | $21.73M |
| Other Current Assets | $6.41M | $7.54M | $8.53M | $9.54M | $11.53M | $10.91M |
| Total Current Assets | $27.33M | $25.77M | $26.07M | $28.27M | $29.16M | $30.34M |
| Properties | $67.61M | $68.64M | $69.72M | $70.60M | $75.70M | $76.80M |
| Machinery Furniture Equipment | $9.10M | $9.09M | $9.09M | $9.09M | $8.87M | $8.87M |
| Leases | $10.75M | $10.75M | $10.75M | $10.81M | $10.81M | $10.81M |
| Accumulated Depreciation | $-75.40M | $-72.53M | $-69.51M | $-66.96M | $-65.64M | $-62.54M |
| Investments And Advances | 0.00 | $8.04M | $24.94M | $29.51M | $55.51M | $80.67M |
| Other Non Current Assets | $13.82M | $37.39M | $37.28M | $37.60M | $33.83M | $33.39M |
| Total Non Current Assets | $12.27M | $15.82M | $17.91M | $18.79M | $21.64M | $24.53M |
| Total Assets | $39.60M | $41.59M | $43.98M | $47.06M | $50.80M | $54.87M |
| Accounts Payable | $4.93M | $4.27M | $3.70M | $4.85M | $5.06M | $5.39M |
| Accrued Expenses | $23.40M | $9.79M | $28.13M | $26.82M | $24.96M | $10.47M |
| Total Current Liabilities | $28.33M | $32.51M | $31.83M | $31.68M | $30.02M | $35.52M |
| Long Term Debt | $72.63M | $75.05M | $77.13M | $79.24M | $81.29M | $83.25M |
| Other Non Current Liabilities | $16.12M | $15.80M | $15.47M | $15.12M | $11.28M | $7.76M |
| Total Non Current Liabilities | $88.75M | $90.85M | $92.61M | $94.36M | $92.57M | $91.01M |
| Total Liabilities | $11.71M | $12.34M | $12.44M | $12.60M | $12.26M | $12.65M |
| Common Stock | 245,000.00 | 229,000.00 | 223,000.00 | 220,000.00 | 219,000.00 | 212,000.00 |
| Retained Earnings | $-205.33M | $-201.07M | $-197.19M | $-193.05M | $-187.96M | $-181.98M |
| Other Shareholders Equity | -183,000.00 | 269,000.00 | 235,000.00 | -45,000.00 | 43,000.00 | -89,000.00 |
| Total Shareholders Equity | $27.89M | $29.25M | $31.53M | $34.46M | $38.54M | $42.22M |
| Additional Paid In Capital | $233.21M | $230.28M | $228.68M | $227.49M | $226.47M | $224.19M |
| Short Term Debt | N/A | $8.21M | N/A | N/A | N/A | $7.51M |
| Pensions | N/A | $10.24M | N/A | N/A | N/A | $12.15M |